SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-12-229568
Filing Date
2012-05-14
Accepted
2012-05-14 06:06:59
Documents
3
Period of Report
2012-05-10
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d352313d8k.htm 8-K 21146
2 PRESS RELEASE d352313dex991.htm EX-99.1 21063
3 GRAPHIC g3523131_image.jpg GRAPHIC 8187
  Complete submission text file 0001193125-12-229568.txt   54769
Mailing Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119
Business Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062827100
CELL THERAPEUTICS INC (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12465 | Film No.: 12836420
SIC: 2834 Pharmaceutical Preparations